Impact of Type 1 Diabetes and Body Weight Status on Cardiovascular Risk Factors in Adolescent Children

Journal of Clinical Hypertension

Volumn 13, Issue 5, 2011, Pages 351-356

  Krishnan, Sowmya ^a   Copeland, Kenneth C ^a   Bright, Brianna C ^a,b   Gardner, Andrew W ^a   Blackett, Piers R ^a   Fields, David A ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN C3; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VISCOELASTICITY;

ADOLESCENT; APOLIPOPROTEIN C-III; BLOOD GLUCOSE; BODY COMPOSITION; BODY WEIGHT; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; LIPIDS; MALE; OVERWEIGHT; RISK FACTORS; YOUNG ADULT;

EID: 79955589502     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2010.00395.x     Document Type: Article

References (23)

1. Onkamo P, Väänänen S, Karvonen M, et al. Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends. Diabetologia. 1999;42:1395-1403.
2. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med. 1999;16:466-471.
3. Libby P, Nathan DM, Abraham K, et al. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation. 2005;111:3489-3493.
4. Krolewski AS, Kosinski EJ, Warram JH, et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol. 1987;59:750-755.
5. Diabetes, Control, Complications, Trial Research Group. The Effect Of Intensive Treatment Of Diabetes On The Development And Progression Of Long-Term Complications In Insulin-Dependent Diabetes Mellitus. N Engl J Med. 1993;329:977-986.
6. Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care. 1995;18:1415-1427.
7. McGill HC Jr, McMahan CA, Herderick EE, et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002;105:2712-2718.
8. Gardner AW, Parker DE. Association between arterial compliance and age in participants 9 to 77years old. Angiology. 2010;61:37-41.
9. Short KR, Blackett PR, Gardner AW, et al. Vascular health in children and adolescents: effects of obesity and diabetes. Vasc Health Risk Manag. 2009;5:973-990.
10. Curry MD, McConathy WJ, Fesmire JD, Alaupovic P. Quantitative determination of human apolipoprotein C-III by electroimmunoassay. Biochim Biophys Acta. 1980;617:505-513.
11. Maahs DM, Maniatis AK, Nadeau K, et al. Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus. J Pediatr. 2005;147:544-546.
12. Kershnar AK, Daniels SR, Imperatore G, et al. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: The search for diabetes in youth study. J Pediatr. 2006;149:314-319.
13. Su JW, Lambert JE, Clandinin MT, et al. Impaired postprandial metabolism of apolipoprotein B48-containing remnant particles in normolipidemic subjects with brittle type 1 diabetes. Diabetes Care. 2009;32:e21.
14. Klein RL, McHenry MB, Lok KH, et al. Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort. J Diabetes Complications. 2005;19:18-25.
15. Olivieri O, Bassi A, Stranieri C, et al. Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J Lipid Res. 2003;44:2374-2381.
16. Alaupovic P, Blackett P, Wang W, et al. Characterization of the metabolic syndrome by apolipoproteins in the Oklahoma Cherokee. J Cardiometab Syndr. 2008;3:193-199.
17. Blackett PR, Blevins KS, Quintana E, et al. ApoC-III bound to apoB-containing lipoproteins increase with insulin resistance in Cherokee Indian youth. Metab Clin Exp. 2005;54:180-187.
18. Sacks FM, Alaupovic P, Moye LA, et al. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation. 2000;102:186-192.
19. Ooi EMM, Barrett PHR, Chan DC, et al. Apolipoprotein C-III: understanding an emerging cardiovascular risk factor. Clin Sci. 2008;114:611-624.
20. Stettler C, Suter Y, Allemann S, et al. Apolipoprotein B as a long-term predictor of mortality in type 1 diabetes mellitus: a 15-year follow up. J Intern Med. 2006;260:272-280.
21. Haller MJ, Samyn M, Nichols WW, et al. Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. Diabetes Care. 2004;27:2911-2917.
22. Jarvisalo MJ, Raitakari M, Toikka JO, et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation. 2004;109:1750-1755.
23. Dangardt F, Osika W, Volkmann R, et al. Obese children show increased intimal wall thickness and decreased pulse wave velocity. Clin Physiol Funct Imaging. 2008;28:287-293.